Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14565400 | 0.90 | CARM1 (1.00) | CARM1KLKB1 | |
| SCHEMBL14565459 | 0.89 | CARM1 (0.84) | CARM1KLKB1 | |
| SCHEMBL14565455 | 0.88 | CARM1 (0.83) | CARM1KLKB1 | |
| SCHEMBL14565443 | 0.88 | CARM1 (0.84) | CARM1 | |
| SCHEMBL14565460 | 0.87 | CARM1 (0.90) | CARM1KLKB1 | |
| SCHEMBL14565458 | 0.87 | CARM1 (0.81) | CARM1KLKB1 | |
| SCHEMBL14565456 | 0.86 | CARM1 (0.80) | CARM1KLKB1 | |
| SCHEMBL14565482 | 0.86 | CARM1 (0.80) | CARM1KLKB1 | |
| SCHEMBL14565461 | 0.86 | CARM1 (0.86) | CARM1KLKB1 | |
| SCHEMBL14565465 | 0.86 | CARM1 (0.83) | CARM1KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070060589-A1 | Inhibitors of protein arginine methyl transferases | BRISTOL-MYERS SQUIBB COMPANY | 2007-03-15 | — | — | US | disclosed |
| US-20070060589-A1 | Inhibitors of protein arginine methyl transferases | BRISTOL-MYERS SQUIBB COMPANY | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060589-A1 | Inhibitors of protein arginine methyl transferases | PRMT1, PRMT3, PRMT6 | CARM1 20/4885KLKB1 3255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.